Cite
HARVARD Citation
Vogel, A. et al. (n.d.). 618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR). Annals of oncology. p. . [Online].